Adaptive Biotechnologies Corp
(ADPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 85,305 |
| Marketable Securities | 106,845 |
| Receivables | 5,582 |
| Inventories | 4,792 |
| Other current assets | 2,723 |
| TOTAL | $205,247 |
| Non-Current Assets | |
| Investments And Advances | 8,905 |
| Other Non-Current Assets | 134,383 |
| TOTAL | $143,288 |
| Total Assets | $362,489 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 1,964 |
| Accrued Expenses | 4,105 |
| Other current liabilities | 14,934 |
| TOTAL | $21,003 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 375 |
| TOTAL | $4,769 |
| Total Liabilities | $25,772 |
| Shareholders' Equity | |
| Common Shares | 1 |
| Retained earnings | -249,423 |
| Other shareholders' equity | 561,167 |
| TOTAL | $336,717 |
| Total Liabilities And Equity | $362,489 |